Voltron Therapeutics, Inc.’s Scientific Co-Founder Dr. Mark C. Poznansky has Guest Essay Published in the New York Times
NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that a the Companys Scientific Co-Founder, Dr. Mark C. Poznanskys guest essay titled The Vaccines We Have Are Good.
- NEW YORK, July 20, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that a the Companys Scientific Co-Founder, Dr. Mark C. Poznanskys guest essay titled The Vaccines We Have Are Good.
- But They Could Be So Much Better , was published in the New York Times on June 10, 2021.
- Dr. Poznansky also serves as a scientific founder for Voltron Therapeutics, helping to advise on the early clinical research and implementation of testing in the clinical setting among other things.
- As a Scientific Co-Founder of Voltron Therapeutics, Dr. Poznansky has been instrumental in the development of HaloVax, a Self-Assembling Vaccine (SAV) against COVID-19.